Literature DB >> 11998548

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

Eugène P van Puijenbroek1, Andrew Bate, Hubert G M Leufkens, Marie Lindquist, Roland Orre, Antoine C G Egberts.   

Abstract

PURPOSE: A continuous systematic review of all combinations of drugs and suspected adverse reactions (ADRs) reported to a spontaneous reporting system, is necessary to optimize signal detection. To focus attention of human reviewers, quantitative procedures can be used to sift data in different ways. In various centres, different measures are used to quantify the extent to which an ADR is reported disproportionally to a certain drug compared to the generality of the database. The objective of this study is to examine the level of concordance of the various estimates to the measure used by the WHO Collaborating Centre for International ADR monitoring, the information component (IC), when applied to the dataset of the Netherlands Pharmacovigilance Foundation Lareb.
METHODS: The Reporting Odds Ratio--1.96 standard errors (SE), proportional reporting ratio--1.96 SE, Yule's Q--1.96 SE, the Poisson probability and Chi-square test of all 17,330 combinations were compared with the IC minus 2 standard deviations. Additionally, the concordance of the various tests, in respect to the number of reports per combination, was examined.
RESULTS: In general, sensitivity was high in respect to the reference measure when a combination of point- and precision estimate was used. The concordance increased dramatically when the number of reports per combination increased.
CONCLUSION: This study shows that the different measures used are broadly comparable when four or more cases per combination have been collected.

Entities:  

Mesh:

Year:  2002        PMID: 11998548     DOI: 10.1002/pds.668

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  263 in total

Review 1.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Safety profile of enantiomers vs. racemic mixtures: it's the same?

Authors:  Céline Caillet; Laurence Chauvelot-Moachon; Jean-Louis Montastruc; Haleh Bagheri
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  Use of measures of disproportionality in pharmacovigilance: three Dutch examples.

Authors:  Antoine C G Egberts; Ronald H B Meyboom; Eugène P van Puijenbroek
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions.

Authors:  Eugène van Puijenbroek; Willem Diemont; Kees van Grootheest
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  Application of data mining techniques in pharmacovigilance.

Authors:  Andrew M Wilson; Lehana Thabane; Anne Holbrook
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

6.  Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study.

Authors:  Véronique Pizzoglio; Ismaïl Ahmed; Pascal Auriche; Pascale Tuber-Bitter; Françoise Haramburu; Carmen Kreft-Jaïs; Ghada Miremont-Salamé
Journal:  Eur J Clin Pharmacol       Date:  2011-12-06       Impact factor: 2.953

7.  Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR.

Authors:  Franck Maschino; Caroline Hurault-Delarue; Leila Chebbane; Vincent Fabry; Jean Louis Montastruc; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

8.  Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection.

Authors:  Sandra de Bie; Katia M C Verhamme; Sabine M J M Straus; Bruno H Ch Stricker; Miriam C J M Sturkenboom
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

9.  Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signalling.

Authors:  Yolanda Alvarez; Ana Hidalgo; Francois Maignen; Jim Slattery
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

10.  An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.

Authors:  Xiaofeng Zhou; Sundaresan Murugesan; Harshvinder Bhullar; Qing Liu; Bing Cai; Chuck Wentworth; Andrew Bate
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.